Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing wound infection risk after open versus laparoscopic gallbladder removal

Official title: Comparison of Frequency of Wound Infection Between Open and Laparoscopic Cholecystectomy

Run by Lady Reading Hospital, Pakistan · NCT07103707 · Data updated 2026-11-12

This will see if open or laparoscopic gallbladder removal causes more wound infections in adults 18–65 with symptomatic gallstones.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment122 (estimated)
SponsorLady Reading Hospital, Pakistan
Government
Locations1 site (Peshawar, Khyber Pakhtunkhwa)
StatusRecruiting
StartedAugust 2025
Main results expectedAugust 2026
Study endsAugust 2026
Registry record updatedAugust 5, 2025
Trial IDNCT07103707 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with symptomatic cholelithiasis who are ASA I–II and planned for open or laparoscopic cholecystectomy, and who do not have diabetes or other listed exclusion conditions, are ideal candidates.

Probably not a fit

Patients with diabetes, immunocompromised states, acute cholecystitis, empyema, gallbladder perforation, choledocholithiasis, portal hypertension, abnormal clotting tests, or pregnancy are excluded and would not be expected to benefit from joining this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–65 with symptomatic cholelithiasis who are ASA I–II and scheduled for cholecystectomy will undergo either open or laparoscopic surgery and have their incision sites monitored for infection. Wound symptoms such as redness, pain, and cloudy drainage will be recorded and participants will return for an outpatient follow-up at one week. Patients with diabetes, immunocompromise, acute cholecystitis, gallbladder perforation, choledocholithiasis, portal hypertension, abnormal clotting, or pregnancy are excluded. The comparison is conducted at a single center (Lady Reading Hospital/associated site in Peshawar) to determine differences in postoperative wound infection frequency.

Why it matters

Potential benefit: If successful, the results could help surgeons choose the approach with lower wound infection risk and reduce postoperative complications and recovery time.

How similar studies have gone: Previous research generally shows lower wound infection rates after laparoscopic compared with open cholecystectomy, so this study repeats that comparison in a local patient population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Both genders

  * Patients aged 18 to 65 years
  * Symptomatic cholelithiasis as per operational definition
  * Undergoing cholecystectomy (open/laparoscopic)
  * ASA score I/II (Annexure-II)

Exclusion Criteria:

* ● H/o diabetes mellitus

  * H/o immunocompromised state (e.g. HIV, steroid use)
  * H/o acute cholecystitis
  * H/o empyema gallbladder
  * H/o gallbladder perforation ● H/o choledocholithiasis
  * H/o portal hypertension
  * H/o abnormal blood clotting profiles (PTT \>15 seconds, APTT \>20 seconds)
  * H/o pregnancy on HCG

Where it's running

  • Moeez u din khan
    Peshawar, Khyber Pakhtunkhwa, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Ahmad faraz, AP GS(FCPS) — Lady reading hospital peshawar
  • Study coordinator: Moeez u din khan, PGR GS
  • Email: moeezk442@gmail.com
  • Phone: +923489548857

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.